Evaluation of artesunate-mefloquine as a novel alternative treatment for schistosomiasis in African children (SchistoSAM): protocol of a proof-of-concept, open-label, two-arm, individually-randomised controlled trial

Clémentine Roucher, Isabel Brosius, Moustapha Mbow, Babacar Thiendella Faye, Annelies De Hondt, Bart Smekens, Diana Arango, Christophe Burm, Achilleas Tsoumanis, Linda Paredis, Yven van Herrewege, Idzi Potters, Badara Cisse, Souleymane Mboup, Katja Polman, Emmanuel Bottieau

Research output: Contribution to journal › A1: Web of Science-article › peer-review

99 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Evaluation of artesunate-mefloquine as a novel alternative treatment for schistosomiasis in African children (SchistoSAM): protocol of a proof-of-concept, open-label, two-arm, individually-randomised controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences